Literature DB >> 14693125

Neurotropism of swine haemagglutinating encephalomyelitis virus (coronavirus) in mice depending upon host age and route of infection.

N Hirano1, R Nomura, T Tawara, K Tohyama.   

Abstract

Mice aged 1, 4 or 8 weeks were inoculated with haemagglutinating encephalomyelitis virus (HEV), strain 67N, by the intracerebral (i.c.), intranasal (i.n.), intraperitoneal (i.p.), subcutaneous (s.c.), intravenous (i.v.) or oral route, with different doses. In 1-week-old mice, mortality and mean time to death were mostly the same regardless of the inoculation route, except for the oral route, which appeared to be the least effective. The virus killed 4-week-old mice readily by all routes of inoculation except the oral, and 8-week-old mice by i.c., i.n. or s.c. inoculation. In descending order of efficacy, the routes of HEV infection were: i.c., i.n., s.c., i.p., i.v. and oral. To follow the spread of HEV from peripheral nerves to the central nervous system (CNS), the virus was inoculated subcutaneously into the right hind leg of 4-week-old mice. The virus was first detected in the spinal cord on day 2, and in the brain on day 3. The brain titres became higher than those of the spinal cord, reaching a maximum of 10(7)PFU/0.2 g when the animals were showing CNS signs. Viral antigen was first detected immunohistochemically in the lumbar spinal cord and the dorsal root ganglion ipsilateral to the inoculated leg; it was detected later in the pyramidal cells of the hippocampus and cerebral cortex, and in the Purkinje cells of the cerebellum but not in the ependymal cells, choroid plexus cells or other glial cells. The infected neurons showed no cytopathological changes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14693125      PMCID: PMC7127506          DOI: 10.1016/s0021-9975(03)00083-5

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


Introduction

Haemagglutinating encephalomyelitis virus (HEV), a coronavirus, causes vomiting and wasting disease, and encephalomyelitis in piglets (Andries and Pensaert, 1980a, Andries and Pensaert, 1980b, Siddell et al., 1983). Greig and Girard (1963) isolated the virus from the brains of sucking pigs with encephalomyelitis. The disease was produced experimentally in piglets by oronasal inoculation (Alexander, 1962). In England, Cartwright reported the isolation of an antigenically similar virus from sucking pigs showing anorexia, depression and vomiting, without encephalomyelitis. In America, Mengeling and Cutlip (1976) demonstrated that both major clinical forms of the disease (vomiting and wasting, and encephalitis) were reproduced by inoculation with the same field isolate from pigs. Yagami produced fatal encephalitis in mice aged 35 days by the intracerebral (i.c.) inoculation of mouse-passaged HEV (strain 67N), but mice aged 20 or more days were resistant, even to large doses, when the virus was administered by the intranasal (i.n.), intraperitoneal (i.p.) or subcutaneous (s.c.) route. Hirano reported successful propagation and plaque assay of HEV 67N in cultures of the established cell line, SK-K. Rats aged 1, 2, 4 or 8 weeks were subsequently inoculated with SK-K-grown virus by Hirano in an experiment in which the routes of infection, in descending order of efficacy, were i.c., i.n., s.c., i.p., i.v. and oral. Rats aged 1 or 2 weeks were generally similar in terms of mortality and mean time to death, regardless of inoculation route, except for the oral route. Eight-week-old rats inoculated by the i.c., i.n. or s.c. route died, but those inoculated by other routes survived. In rats inoculated by the i.c. route, HEV antigen was found in the pyramidal cells of the hippocampus and cerebral cortex, and later in the large-sized neurons of the pons and spinal cord and in the Purkinje cells of the cerebellum, but not in the ependymal cells, choroid plexus cells or other glial cells of the central nervous system (CNS). In the field of neuroscience, neurotropic viruses such as pseudorabies virus (PRV), herpes simplex virus (HSV) and rabies virus have been used as trans-neuronal tracers for studying neuronal connections of rats and mice (Kuypers and Ugolini, 1990). Previous studies in rats showed that HEV infected neurons but not glial cells in the CNS via trans-synaptic pathways after inoculation by the s.c. route (Hirano ), i.c. route (Hirano ) and i.n. route (Hirano ); degenerative changes were not found in the HEV-infected neurons. Except for these studies in rats our experience of experimental HEV infection in laboratory animals is limited to 4-week-old mice, 2-month-old Syrian hamsters and 3-week-old Mongolian gerbils (Hirano ). The value of HEV as a trans-synaptic tracer for analysing the neuroanatomical connections of rats and mice would be enhanced by further information on infections in mice. The aim of the present study, therefore, was to define the neurotropism of HEV in mice of different ages, inoculated by various routes.

Materials and Methods

Mice

Specific pathogen-free ICR (outbred) mice were obtained from a commercial breeder (SLC, Hamamatsu, Japan) to supply offspring aged 1, 4 or 8 weeks. In most experiments, male mice were used and the animals were given free access to commercial pellets and water. Sucking mice were nursed by their dams. The mice were kept in lamina-flow units throughout the experiments, which were performed in accordance with the guidelines for animal experimentation of Iwate University.

Virus and Assay

The plaque-purified 67N strain of HEV (Mengeling ) was propagated and assayed for infectivity by the plaque method in SK-K cell culture, as described previously (Hirano ), the infectivity titre being expressed in plaque-forming units (PFU). For viral assay of the brain and spinal cord, 10% (w/v) homogenates were prepared in Eagle's minimum essential medium, and the supernates were subjected to the infectivity assay after centrifugation at 2000 rpm (1000  ) at 4 °C for 10 min.

Inoculation of Mice

The experimental design is shown in Table 1 . Mice aged 1, 4 or 8 weeks (n=420) were inoculated by the i.c., i.n., i.p., s.c., i.v. or oral route with various doses. The dose volume was 0.02 ml for i.c. and i.n. inoculation. For other routes of inoculation it was 0.2 ml, except that 1-week-old mice inoculated by the oral route were given 0.02 ml. Controls (two mice for each route of inoculation) were given fluid from uninfected SK-K cell culture. The animals were observed daily for 14 days after inoculation.
Table 1

Susceptibility of mice aged 1,4 or 8 weeks to inoculation with the virus by different routes

Results* in mice aged (weeks)
RouteDose (PFU)148
Intracerebral105ND5/4.2(4–5)5/4.8(4–6)
1045/3.0(3–4)5/4.2(3–4)5/5.6(5–6)
1035/3.6(3–4)5/5.3(5–6)5/6.6(6–7)
1025/3.6(3–4)5/6.5(5–8)4/7(7)
105/3.8(3–4)3/6.3(5–7)1/8(8)


Intranasal105ND5/6.8(6–7)5/7.6(7–8)
1045/4.4(3–5)5/10.0(6–12)5/10.5(8–14)
1035/5.0(4–6)2/10.0(10)2/12.5(12–13)
1025/6.0(5–7))00
103/6.0(5–7)00


Intraperitoneal106ND5/4.4(4–5)3/6.3(6–7)
105ND5/5.0(4–7)1/10(10)
1045/2.6(2–3)2/7(7)0
1035/3.3(3–4)1/7(7)0
1025/4.3(3–6)00
104/4.3(4–5)00


Subcutanous106ND5/5.4(4–6)5/6.5(6–7)
105ND5/8.2(5–11)5/7.0(6–8)
1045/2.6(2–3)5/8.4(7–12)1/8(8)
1035/3.2(3–4)1/9(9)0
1025/3.7(3–4)00
101/7(7)NDND


Intravenous106ND5/5.6(5–6)0
105ND5/5.0(5–7)0
104ND2/6.0(5–7)0
103ND00


Oral106ND00
1055/5.0(4–6)00
1042/6.5(6–7)00

ND, not done.

Deaths in groups of 5/mean number of days (and range) to death.

Susceptibility of mice aged 1,4 or 8 weeks to inoculation with the virus by different routes ND, not done. Deaths in groups of 5/mean number of days (and range) to death. To examine the growth and spread of the virus in the CNS from peripheral tissue, 30 mice aged 4 weeks were inoculated subcutaneously over the right knee with 105 PFU. Five mice were killed daily on each of days 1 to 5, three mice for viral assay, and two for immunohistochemistry (IHC).

IHC

The infected mice were perfused with phosphate-buffered saline and a fixative containing 4% para formaldehyde under deep anaesthesia with pentobarbital. Sections of the brain and spinal cord, cut with a freezing microtome, were treated with anti-HEV 67N mouse antibody (1 in 1000) at 4 °C overnight, and then labelled with fluorescein isothiocyanate (FITC)-conjugated goat antiserum against mouse IgG at room temperature for 2 h. The sections were examined under a confocal laser scanning microscope (Olympus and Nikon, Tokyo, Japan).

Results

The results are shown in Table 1. Sucking mice aged 1 week given ≥100 PFU by all routes except for the oral route invariably died; i.v. inoculation in mice of this age was not tested. By the oral route, 104 PFU killed only two of five mice; 105 PFU, however, killed all animals. Sucking mice infected by the i.n., i.p. or s.c. route died in 2–7 days. In mice aged 4 weeks, i.c. infection killed three of five mice given only 10 PFU, and all mice given ≥100 PFU, the time of death ranging from 3–8 days. Infection by the i.n., i.p., s.c. or i.v. route killed some or all animals, depending on dose. Mice of this age group were completely resistant to oral infection, even with the large dose of 106 PFU. In mice aged 8 weeks, only i.c. inoculation produced deaths (four of five mice) with a dose as small as 100 PFU. Inoculation by the i.n. and s.c. routes with doses of 104 and 105 PFU, respectively, was invariably lethal in 6–14 days. Intraperitoneal inoculation was comparatively ineffective, and inoculation by the i.v. and oral routes completely ineffective. HEV was detected in the brains of mice that died, but not in animals that survived or in uninfected controls.

Viral Growth in the Spinal Cord and Brain

Based on the results obtained in 4-week-old mice, mice of this age were inoculated by the s.c. route in the right hind leg with 105 PFU. On day 4, the mice developed CNS signs. On day 6, five mice died. As shown in Fig. 1 , the virus was first detected in the spinal cord on day 2 after inoculation and in the brain on day 3. On day 4, the infectivity titres of the spinal cord had increased, reaching a maximum of 106 PFU/0.2 g; they declined later. The brain titres became higher than those of spinal cord, reaching on day 5 a maximum of 107 PFU/0.2 g. Virus was not detected in the liver or spleen of any animal.
Fig. 1

HEV 67N growth in the spinal cord and brain of mice, killed in groups of three, after subcutaneous (s.c.) inoculation with 105 PFU in the right hind leg. ○- - -○, Spinal cord; ●- - -●, brain.

HEV 67N growth in the spinal cord and brain of mice, killed in groups of three, after subcutaneous (s.c.) inoculation with 105 PFU in the right hind leg. ○- - -○, Spinal cord; ●- - -●, brain.

Viral Spread from the Peripheral Nerves to the CNS

After s.c. inoculation, HEV antigen was first detected immunohistochemically on day 2 in the lumbar spinal cord and lumbar dorsal root ganglion (DRG) ipsilateral to the inoculated leg. On day 3, the viral antigen was detected in many neurons in the ventral and dorsal horn of the lumbar spinal cord (Fig. 2a, b) and large-sized neurons in the DRG (Fig. 2c) but not in the contralateral DRG. In the brain, antigen was first detected in pyramidal cells of the cerebral cortex and hippocampus. On day 4, it was detected in the contralateral half of the spinal cord and DRG. In the brain, antigen-positive neurons had increased in number and were distributed widely in the cerebral cortex (Fig.3a and b), hippocampus (Fig. 3c and d), pons and midbrain. As shown in Fig. 3a, b, the antigen-positive neurons in the cortex were distributed in layers III and V but not II and IV. In the cerebellum, viral specific antigen was detected in the Purkinje cells (Fig. 3e, f) but in only a few granular cells. HEV antigen tended to be found in the large-sized neurons but not in the ependymal cells, choroid plexus cells or other glial cells. Infected neurons appeared to be free from cytopathological changes.
Fig. 2a–c

(a and b) Antigen-positive neurons in the spinal cord on day 3 after s.c. inoculation. (c) Antigen-positive cells in the dorsal root ganglion ipsilateral to the inoculated leg on day 3. IHC. Bars, 100 μm (a and c); 50 μm (b).

Fig. 3a–f

(a and b) Antigen-positive pyramidal cells in the cerebral cortex on day 4. (Arrowheads: pial surface). (c and d) Antigen-positive pyramidal cells in the hippocampus on day 4. (e and f) Antigen positive Purkinje cells of the cerebellum on day 4. (Arrows: pial surface). IHC. Short bar, 100 μm (e). Long bar, 100 μm (f). Figs 3a and c are at the same magnification as 3e. Figs 3b and d are at the same magnification as 3f.

(a and b) Antigen-positive neurons in the spinal cord on day 3 after s.c. inoculation. (c) Antigen-positive cells in the dorsal root ganglion ipsilateral to the inoculated leg on day 3. IHC. Bars, 100 μm (a and c); 50 μm (b). (a and b) Antigen-positive pyramidal cells in the cerebral cortex on day 4. (Arrowheads: pial surface). (c and d) Antigen-positive pyramidal cells in the hippocampus on day 4. (e and f) Antigen positive Purkinje cells of the cerebellum on day 4. (Arrows: pial surface). IHC. Short bar, 100 μm (e). Long bar, 100 μm (f). Figs 3a and c are at the same magnification as 3e. Figs 3b and d are at the same magnification as 3f.

Discussion

Yagami reported that mice aged ≥20 days were resistant to i.n., i.p. or s.c. inoculation with mouse-passaged HEV in the large dose of 106 LD50. However, in the present study, the virus readily killed 4-week-old mice by i.c., i.n., i.p., i.v. or s.c. inoculation, and 8-week-old mice by routes of inoculation other than i.p., i.v. or oral. These differences in results between the two studies may have been due to the use of different mouse strains. The present study showed that the neurotropism of HEV 67N in mice was dependent on the age of the host at the time of infection and on the route of inoculation. The results were largely similar to those obtained in rats of different ages by various routes of inoculation (Hirano ). Following s.c. inoculation into the hind leg, the virus was first recovered from the spinal cord and later from the brain. HEV antigen was first detected immunohistochemically in the lumbar spinal cord and lumbar DRG ipsilateral to the inoculated leg and later in pyramidal cells of the cerebral cortex and hippocampus, and in Purkinje cells of the cerebellum. In the cortex, antigen-positive neurons were distributed in the cell layers III and V. HEV antigen was detected mainly in neurons, but not in ependymal cells, choroid plexus cells or other glial cells. These findings were similar to those in previous studies of rats inoculated by the s.c. route (Hirano ), suggesting that the virus spreads trans-synaptically along the neuronal pathways from the peripheral nerves to the CNS. Recent immunohistochemical studies (unpublished) in which CNS sections from HEV-infected rats and mice were double- or triple-labelled with antibodies to HEV, glial fibrillary acidic protein (for astrocytes) and TB4 antibody (for microglial cells) confirmed that HEV does not infect glial cells. Among neurotropic viruses, rabies virus, PRV, HSV and Borna disease virus (BDV) are known to spread from peripheral nerves to the CNS. There are, however, differences in the neurotropic properties of these viruses. Rabies virus infects predominantly neurons, such as pyramidal cells in the hippocampus and cerebral cortex and Purkinje cells in the cerebellum, but not glial cells; cytolytic and inflammatory reactions in the CNS do not occur in mice inoculated in the hind leg (Johnson, 1965). PRV (Rinaman ), and BDV (Carbone ), however, infect not only neurons but also glial cells. PRV causes cytolytic damage in the CNS (Rinaman et al., 1993, Sur et al., 1995). BDV produces severe inflammation in the CNS (Hirano et al., 1983, Carbone et al., 1989). In contrast, the brains of rats infected with HEV by the s.c. (Hirano ), i.c. (Hirano ), or i.n. route (Hirano ) showed no distinct neuronal changes of inflammatory reactions. It was recently found (unpublished observation) that HEV spread in the regenerated axons but not in Schwann cells of the peripheral nervous system after transection and suturing of the sciatic nerve of rats. The present study showed that HEV was strictly neurotropic but did not cause distinct pathological changes in the CNS, thus resembling rabies virus. HEV, being harmless for human beings, is handled more easily than rabies virus or HSV in the laboratory. It may prove valuable as a new trans-synaptic tracer for analysing neuroanatomical connections in the CNS of mice and rats.
  18 in total

1.  Viral encephalomyelitis of swine in Ontario--experimental and natural transmission.

Authors:  T J ALEXANDER
Journal:  Am J Vet Res       Date:  1962-07       Impact factor: 1.156

2.  Characteristics of a coronavirus (strain 67N) of pigs.

Authors:  W L Mengeling; A D Boothe; A E Ritchie
Journal:  Am J Vet Res       Date:  1972-02       Impact factor: 1.156

3.  Experimental rabies. Studies of cellular vulnerability and pathogenesis using fluorescent antibody staining.

Authors:  R T Johnson
Journal:  J Neuropathol Exp Neurol       Date:  1965-10       Impact factor: 3.685

4.  Vomiting and wasting disease of piglets.

Authors:  S F Cartwright; M Lucas; J P Cavill; A F Gush; T B Blandford
Journal:  Vet Rec       Date:  1969-02-15       Impact factor: 2.695

5.  Spread of hemagglutinating encephalomyelitis virus (HEV) in the CNS of rats inoculated by intranasal route.

Authors:  N Hirano; K Tohyama; H Taira; T Hashikawa
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

6.  Pathogenicity of field isolants of hemagglutinating encephalomyelitis virus for neonatal pigs.

Authors:  W L Mengeling; R C Cutlip
Journal:  J Am Vet Med Assoc       Date:  1976-02-01       Impact factor: 1.936

7.  Spread of swine hemagglutinating encephalomyelitis virus from peripheral nerves to the CNS.

Authors:  N Hirano; K Tohyama; H Taira
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

8.  Virus isolated and immunofluorescence in different organs of pigs infected with hemagglutinating encephalomyelitis virus.

Authors:  K Andries; M B Pensaert
Journal:  Am J Vet Res       Date:  1980-02       Impact factor: 1.156

9.  Study of transneuronal passage of pseudorabies virus in rat central nervous system by use of immunohistochemistry and in situ hybridization.

Authors:  J H Sur; S B Kim; F A Osorio; O K Moon
Journal:  Am J Vet Res       Date:  1995-09       Impact factor: 1.156

10.  Coronaviridae.

Authors:  S G Siddell; R Anderson; D Cavanagh; K Fujiwara; H D Klenk; M R Macnaughton; M Pensaert; S A Stohlman; L Sturman; B A van der Zeijst
Journal:  Intervirology       Date:  1983       Impact factor: 1.763

View more
  15 in total

1.  Ulk1 Governs Nerve Growth Factor/TrkA Signaling by Mediating Rab5 GTPase Activation in Porcine Hemagglutinating Encephalomyelitis Virus-Induced Neurodegenerative Disorders.

Authors:  Zi Li; Kui Zhao; Xiaoling Lv; Yungang Lan; Shiyu Hu; Junchao Shi; Jiyu Guan; Yawen Yang; Huijun Lu; Hongbin He; Feng Gao; Wenqi He
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

2.  Antibody-mediated virus clearance from neurons of rats infected with hemagglutinating encephalomyelitis virus.

Authors:  Norio Hirano; Hideharu Taira; Shigehiro Sato; Tsutomu Hashikawa; Koujiro Tohyama
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

Review 3.  Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans.

Authors:  Marc Desforges; Alain Le Coupanec; Elodie Brison; Mathieu Meessen-Pinard; Pierre J Talbot
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

4.  Development of a dose-response model for SARS coronavirus.

Authors:  Toru Watanabe; Timothy A Bartrand; Mark H Weir; Tatsuo Omura; Charles N Haas
Journal:  Risk Anal       Date:  2010-05-20       Impact factor: 4.000

5.  Coronavirus infection of rat dorsal root ganglia: ultrastructural characterization of viral replication, transfer, and the early response of satellite cells.

Authors:  Yan-Chao Li; Wan-Zhu Bai; Norio Hirano; Tsuyako Hayashida; Tsutomu Hashikawa
Journal:  Virus Res       Date:  2012-01-11       Impact factor: 3.303

6.  The evidence of porcine hemagglutinating encephalomyelitis virus induced nonsuppurative encephalitis as the cause of death in piglets.

Authors:  Zi Li; Wenqi He; Yungang Lan; Kui Zhao; Xiaoling Lv; Huijun Lu; Ning Ding; Jing Zhang; Junchao Shi; Changjian Shan; Feng Gao
Journal:  PeerJ       Date:  2016-09-15       Impact factor: 2.984

7.  miR-142-5p Disrupts Neuronal Morphogenesis Underlying Porcine Hemagglutinating Encephalomyelitis Virus Infection by Targeting Ulk1.

Authors:  Zi Li; Yungang Lan; Kui Zhao; Xiaoling Lv; Ning Ding; Huijun Lu; Jing Zhang; Huiqing Yue; Junchao Shi; Deguang Song; Feng Gao; Wenqi He
Journal:  Front Cell Infect Microbiol       Date:  2017-05-03       Impact factor: 5.293

8.  Genomic characterization and pathogenicity of a porcine hemagglutinating encephalomyelitis virus strain isolated in China.

Authors:  Junchao Shi; Kui Zhao; Huijun Lu; Zi Li; Xiaoling Lv; Yungang Lan; Jiyu Guan; Wenqi He; Feng Gao
Journal:  Virus Genes       Date:  2018-08-04       Impact factor: 2.332

9.  miR-142a-3p promotes the proliferation of porcine hemagglutinating encephalomyelitis virus by targeting Rab3a.

Authors:  Peng Fan; Jiyu Guan; Wenqi He; Xiaoling Lv; Shiyu Hu; Yungang Lan; Kui Zhao; Feng Gao; Fang Li; Gencheng Fan; Hongbin He; Zi Li
Journal:  Arch Virol       Date:  2019-12-13       Impact factor: 2.574

10.  An Experimental Model of Neurodegenerative Disease Based on Porcine Hemagglutinating Encephalomyelitis Virus-Related Lysosomal Abnormalities.

Authors:  Yungang Lan; Zi Li; Zhenzhen Wang; Xinran Wang; Gaili Wang; Jing Zhang; Shiyu Hu; Kui Zhao; Baofeng Xu; Feng Gao; Wenqi He
Journal:  Mol Neurobiol       Date:  2020-09-02       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.